Can You Donate Blood on Wegovy or Semaglutide?

NHS Blood and Transplant (NHSBT) sets its own donor eligibility rules, separate from your prescribing team, check directly with them before assuming you can or cannot donate.
The concern with donating blood on semaglutide is not about risk to you as a donor; it is about ensuring the recipient does not receive medicine they have not been assessed for.
Wegovy is a prescription-only medicine containing semaglutide; any decision to pause or stop it should be discussed with your prescriber first, since stopping can affect your treatment progress.
Rules can change, the most accurate, up-to-date guidance comes from NHSBT's donor eligibility checker or their helpline, not from third-party sources.

If you take Wegovy and want to donate blood, the short answer is that most UK blood services ask donors to pause semaglutide — or wait a set period after their last dose — before donating. The decision ultimately rests with the blood service, not your prescriber, because the concern centres on the recipient rather than you. Wegovy is a prescription-only medicine for weight management, and any decision about continuing or pausing it should involve a clinician who knows your full picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What you need to weigh up before booking a donation appointment

Why blood services set rules around prescription medicines

Blood services screen donors partly to protect recipients. When a donor is on a prescription medicine, the question the blood service asks is whether any trace of that medicine in the donated blood could affect someone receiving a transfusion. With semaglutide (the active ingredient in Wegovy) there is no published evidence of harm to recipients, but NHSBT's standing policy is precautionary: medicines that are not licensed for use in all potential recipient groups (including pregnant women, children, and people with specific conditions) can trigger deferral periods.

This is different from a safety problem with Wegovy itself. The NHS medicines page for semaglutide covers its use and side-effect profile in detail, and nothing there relates to blood donation compatibility. The restriction, where it exists, is a supply-chain precaution on the recipient side.

Blood service guidance is also updated independently of prescribing guidance, so a rule that applied six months ago may have changed. The only reliable source is NHSBT's own donor eligibility tool or helpline. If you are in Scotland, Wales or Northern Ireland, the relevant national blood service may have slightly different rules, always check with them directly.

What the typical deferral picture looks like for semaglutide

A question our prescribers hear most weeks is whether starting Wegovy means giving up blood donation entirely. The answer is no, but timing matters. NHSBT has historically applied a deferral period for donors taking medicines in certain pharmacological classes, meaning you would be asked to wait a specified period after your last dose before donating.

Because semaglutide has a relatively long half-life (roughly one week), a deferral measured in weeks rather than days is consistent with how similar medicines are handled. If you want a thorough look at how Wegovy and blood donation interact, including how deferral periods are typically applied to GLP-1 medicines, that page goes into the detail. The exact period NHSBT applies is theirs to confirm (it can shift when their clinical advisers review the evidence) so treat any figure you read on a forum or general article as a starting point, not the final word.

If you are considering starting Wegovy and blood donation is important to you, this is worth raising at the point of consultation. Pausing treatment temporarily to donate is medically possible, but it should be a planned decision, not an impromptu one. Stopping and restarting a GLP-1 medicine can involve re-titration from a lower dose, which your prescriber would manage. Read more about what Wegovy treatment involves on the semaglutide overview page.

Talking to your prescriber before you act

The practical decision has two parts. First, check with NHSBT (or your national blood service) whether your current dose and timing makes you eligible today. Second, if they say you need to pause, speak to your prescriber before stopping Wegovy (even briefly) because pausing a weight-management medicine without clinical input can disrupt your treatment plan more than people expect.

It is also worth knowing that blood donation eligibility covers a wider picture than just medication. Your haemoglobin level, recent travel, and general health all factor in. The blood service will screen these at the session regardless.

If you are also thinking about how Wegovy interacts with other medicines or circumstances, the page on Wegovy and blood thinners covers a related clinical question. For practical aspects of managing your medicine day-to-day, the guidance on travelling with Wegovy is useful reading.

The MHRA's Yellow Card scheme is the right route if you ever suspect an unexpected reaction, it is available at yellowcard.mhra.gov.uk. For questions specific to your treatment, our prescribers are available seven days a week via aftercare once you are a patient.

The cost question, briefly

Some people researching blood donation on Wegovy are also at the early stage of deciding whether to start treatment. Our dedicated page on whether you can donate blood while on Wegovy is a good first read if that question is what brought you here. If price is part of that calculation, the Wegovy cost page sets out what UK private pricing actually looks like and what a legitimate prescription service includes, worth reading before comparing headline figures across providers.

If you are ready to explore whether Wegovy is clinically appropriate for you, speak to our prescribers through a free consultation. A named clinician reviews every submission (not a piece of software) and your consultation is handled the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions